Target identified which could open the door to personalized treatment for heart failure
An enzyme which cross-links collagen has been identified as a target for personalized treatment in heart failure. The enzyme, termed Lysyl oxidase-like 2, produces fibrosis of the cardiac muscle, which stimulates the development of heart failure when in excess.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.